MedTrace Logo

MR Metabolic Biomarkers for Cervical Cancer

NCT01874548 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 136

Last updated 2016-08-15

No results posted yet for this study

Summary

The purposes of this study are: (1) to develop magnetic resonance (MR) imaging and spectroscopy as surrogate biomarkers for altered cancer metabolism in cervical cancer; (2) to understand the function of human papillomavirus (HPV) infection and autophagy (a cellular catabolic degradation response to stress) in the metabolic alterations in cervical cancer.

Conditions

  • Uterine Cervical Neoplasms

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Gigin Lin, MD, PhD · Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01874548 on ClinicalTrials.gov